NFSG
GILD icon

Newbridge Financial Services Group’s Gilead Sciences GILD Stock Holding History

Newbridge Financial Services Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.7K Sell
140
-7,769
-98% -$1.02M ﹤0.01% 737
2026
Q1 		$1.1M Buy
7,909
+7,652
+2,977% +$1.07M 0.18% 98
2025
Q4 		$31.6K Buy
257
+62
+32% +$7.54K ﹤0.01% 538
2025
Q3 		$21.6K Sell
195
-61
-24% -$6.93K ﹤0.01% 722
2025
Q2 		$28.4K Buy
256
+1
+0.4% +$106 ﹤0.01% 632
2025
Q1 		$28.5K Sell
255
-103
-29% -$10.6K 0.01% 483
2024
Q4 		$33.1K Buy
+358
New +$32.2K 0.01% 504
2024
Q3 		– Sell
-4,165
Closed -$286K – 818
2024
Q2 		$286K Buy
4,165
+2,462
+145% +$164K 0.11% 137
2024
Q1 		$125K Sell
1,703
-925
-35% -$71.1K 0.05% 258
2023
Q4 		$213K Sell
2,628
-626
-19% -$48.7K 0.1% 181
2023
Q3 		$244K Buy
3,254
+1,131
+53% +$87K 0.12% 167
2023
Q2 		$164K Buy
2,123
+336
+19% +$26.8K 0.08% 229
2023
Q1 		$148K Sell
1,787
-147
-8% -$12.2K 0.08% 245
2022
Q4 		$166K Sell
1,934
-1,563
-45% -$124K 0.1% 210
2022
Q3 		$216K Sell
3,497
-92
-3% -$5.8K 0.13% 178
2022
Q2 		$222K Buy
3,589
+529
+17% +$32.8K 0.14% 150
2022
Q1 		$182K Buy
3,060
+255
+9% +$16.3K 0.09% 214
2021
Q4 		$204K Buy
2,805
+104
+4% +$7.16K 0.1% 200
2021
Q3 		$189K Buy
2,701
+3
+0.1% +$211 0.12% 178
2021
Q2 		$186K Sell
2,698
-34
-1% -$2.27K 0.11% 184
2021
Q1 		$177K Buy
2,732
+250
+10% +$16.1K 0.13% 177
2020
Q4 		$145K Sell
2,482
-25
-1% -$1.51K 0.12% 175
2020
Q3 		$158K Buy
+2,507
New +$174K 0.16% 137

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Newbridge Financial Services Group's GILD Position: Q2 2026 in Review

Newbridge Financial Services Group reduced its Gilead Sciences (GILD) stake by 98% in Q2 2026, selling an estimated $1.02M and leaving 140 shares worth $17.7K. The position accounts for ﹤0.01% of the portfolio, ranked #737.

Newbridge Financial Services Group first reported a position in GILD in Q3 2020 and has held it in 23 quarters since. The position peaked at $1.1M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Newbridge Financial Services Group held 140 shares of Gilead Sciences worth $17.7K as of Q2 2026.
  • Newbridge Financial Services Group sold 7,769 Gilead Sciences shares in Q2 2026, an estimated $1.02M.
  • Gilead Sciences made up ﹤0.01% of Newbridge Financial Services Group's portfolio in Q2 2026, its #737 holding.
  • Newbridge Financial Services Group first reported a position in Gilead Sciences in Q3 2020 and has held it in 23 quarters since.
  • Newbridge Financial Services Group's Gilead Sciences position peaked at $1.1M in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Newbridge Financial Services Group's 13F filing for Q2 2026, filed 14 Aug 2026.